Yacon supplementation reduces serum free fatty acids and tumor necrosis factor alpha concentrations in patients with type 2 diabetes

about

Yacon supplementation reduces serum free fatty acids and tumor necrosis factor alpha concentrations in patients with type 2 diabetes

Item

http://www.wikidata.org/entity/Q57649324

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2013

@uk

name

Yacon supplementation reduces ...... patients with type 2 diabetes

@en

Yacon supplementation reduces ...... patients with type 2 diabetes

@nl

type

Item

label

Yacon supplementation reduces ...... patients with type 2 diabetes

@en

Yacon supplementation reduces ...... patients with type 2 diabetes

@nl

prefLabel

Yacon supplementation reduces ...... patients with type 2 diabetes

@en

Yacon supplementation reduces ...... patients with type 2 diabetes

@nl

P1476

Yacon supplementation reduces ...... patients with type 2 diabetes

@en

P2093

Akihiro Kudoh

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Hirai

http://www.w3.org/2001/XMLSchema#string

Koji Hasegawa

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

A central role for JNK in obesity and insulin resistance

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Prebiotics and synbiotics in clinical medicine.

Yacon syrup: beneficial effects on obesity and insulin resistance in humans.

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

P2888

s13340-013-0150-y

P304

165-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13340-013-0150-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroaki Satoh

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

type-2 diabetes